White label – Pompe disease - ClinicalTrials.eu

Study on the Effects of BI 685509 for Patients with Liver Cirrhosis and Portal Hypertension After First Decompensation Event

Not recruiting

2 1
Investigated Diseases:
- Portal hypertension
Investigated Drugs:
- Bi 685509
Study on Botulinum Toxin Type A for Preventing Episodic Migraine in Adults

Not recruiting

3 1 1
Investigated Diseases:
- Migraine
Investigated Drugs:
- Botulinum Toxin Type A – Haemagglutinin Complex
Study on Triple Negative Breast Cancer Treatment with Chemotherapy, Fasting-Mimicking Diet, and Metformin for Preoperative Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
- Metformin Hydrochloride
Study on Budesonide Tablets for Preventing Esophageal Narrowing in Adults After Cancer Tissue Removal

Not recruiting

2 1
Investigated Diseases:
Investigated Drugs:
- Budesonide
+1
Study Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic obstructive pulmonary disease
Investigated Drugs:
Study of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Glofitamab
- Obinutuzumab
Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

Not recruiting

3 1
Investigated Diseases:
- Pulmonary arterial hypertension
Investigated Drugs:
- Seralutinib
+10
Study on Extending Omalizumab Treatment Intervals for Adults with Well-Controlled Chronic Spontaneous Urticaria

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic spontaneous urticaria
Investigated Drugs:
- Omalizumab
Study of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer

Not recruiting

3 1 1
Investigated Diseases:
- Biliary neoplasm
Investigated Drugs:
+1
Study of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies